Icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study

BACKGROUND: The efficacy and safety of epidermal growth factor receptor tyrosine kinase inhibitors have been studied worldwide. However, there are few reports directly comparing the efficacy and safety between icotinib and docetaxel as second-line treatment in lung adenocarcinoma patients who have f...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wei, Zhang, Yan, Xiong, Yu, Dai, Feng-juan, Fan, Qing-xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936811/
https://www.ncbi.nlm.nih.gov/pubmed/27445494
http://dx.doi.org/10.2147/OTT.S99434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936811/
https://www.ncbi.nlm.nih.gov/pubmed/27445494
http://dx.doi.org/10.2147/OTT.S99434

Ejemplares similares